In the last 12 months, insiders at Pyxis Oncology, Inc. ($PYXS) filed 92 transactions with the SEC: 9 open-market purchases totaling $247,804 and 8 sales totaling $97,379. Net insider sentiment: net buying.
Pyxis Oncology, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Sullivan Lara (President and CEO) — 12 transactions totaling $474,962
- Connealy Pamela Ann (CFO & COO) — 5 transactions totaling $174,365
- Connealy Pamela Ann (CFO and COO) — 6 transactions totaling $107,295
- Wadhane Jitendra (Chief Accounting Officer) — 9 transactions totaling $17,874
- HUMPHREY RACHEL (Not found) — 6 transactions totaling $15,918
View all SEC Filings for Pyxis Oncology, Inc. (PYXS).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 21, 2025 | HUMPHREY RACHEL | Not found | S | Common Stock | 13896 | $1.03 | 81,309.0000 | 58,445,765 | 14.60% | 0.02% |
| April 17, 2025 | HUMPHREY RACHEL | Not found | S | Common Stock | 200 | $0.97 | 95,205.0000 | 58,445,765 | 0.21% | 0.00% |
| April 14, 2025 | HUMPHREY RACHEL | Not found | S | Common Stock | 1400 | $0.97 | 95,405.0000 | 58,445,765 | 1.45% | 0.00% |
| March 24, 2026 | Palani Santhosh | Not found | A | Stock Option (Right to Buy) | 45867 | $0.00 | 45,867.0000 | 62,557,386 | 9999.99% | 0.07% |
| March 24, 2026 | HUMPHREY RACHEL | Not found | A | Stock Option (Right to Buy) | 45867 | $0.00 | 45,867.0000 | 62,557,386 | 9999.99% | 0.07% |
| March 24, 2026 | Cline Darren S | Not found | A | Stock Option (Right to Buy) | 45867 | $0.00 | 45,867.0000 | 62,557,386 | 9999.99% | 0.07% |
| March 24, 2026 | Lewis-Hall Freda C | Not found | A | Stock Option (Right to Buy) | 45867 | $0.00 | 45,867.0000 | 62,557,386 | 9999.99% | 0.07% |
| March 24, 2026 | Metzger Michael A | Not found | A | Stock Option (Right to Buy) | 45867 | $0.00 | 45,867.0000 | 62,557,386 | 9999.99% | 0.07% |
| March 24, 2026 | FLAVIN JOHN L | Not found | A | Stock Option (Right to Buy) | 45867 | $0.00 | 45,867.0000 | 62,557,386 | 9999.99% | 0.07% |
| March 24, 2026 | Wadhane Jitendra | Prin Fin & Acct Officer | A | Stock Option (Right to Buy) | 262635 | $0.00 | 262,635.0000 | 62,557,386 | 9999.99% | 0.42% |
| March 24, 2026 | Wadhane Jitendra | Prin Fin & Acct Officer | A | Common Stock | 109461 | $0.00 | 512,882.0000 | 62,557,386 | 27.13% | 0.17% |
| March 24, 2026 | Dupont Jakob | Not found | A | Stock Option (Right to Buy) | 45867 | $0.00 | 45,867.0000 | 62,557,386 | 9999.99% | 0.07% |
| Feb. 3, 2026 | Civik Thomas | Interim CEO | A | Stock Option (Right to Buy) | 690131 | $0.00 | 690,131.0000 | 62,557,386 | 9999.99% | 1.10% |
| March 31, 2025 | Wadhane Jitendra | SVP, Chief Accounting Officer | A | Stock Option (Right to Buy) | 263782 | $0.98 | 263,782.0000 | 58,445,765 | 9999.99% | 0.45% |
| March 31, 2025 | HUMPHREY RACHEL | Not found | A | Stock Option (Right to Buy) | 36979 | $0.98 | 36,979.0000 | 58,445,765 | 9999.99% | 0.06% |
| March 31, 2025 | Lewis-Hall Freda C | Not found | A | Stock Option (Right to Buy) | 36979 | $0.98 | 36,979.0000 | 58,445,765 | 9999.99% | 0.06% |
| March 31, 2025 | Cline Darren S | Not found | A | Stock Option (Right to Buy) | 36979 | $0.98 | 36,979.0000 | 58,445,765 | 9999.99% | 0.06% |
| March 31, 2025 | Dupont Jakob | Not found | A | Stock Option (Right to Buy) | 36979 | $0.98 | 36,979.0000 | 58,445,765 | 9999.99% | 0.06% |
| March 31, 2025 | Palani Santhosh | Not found | A | Stock Option (Right to Buy) | 36979 | $0.98 | 36,979.0000 | 58,445,765 | 9999.99% | 0.06% |
| March 31, 2025 | Civik Thomas | Not found | A | Stock Option (Right to Buy) | 36979 | $0.98 | 36,979.0000 | 58,445,765 | 9999.99% | 0.06% |
| March 31, 2025 | Connealy Pamela Ann | CFO & COO | A | Stock Option (Right to Buy) | 414163 | $0.98 | 414,163.0000 | 58,445,765 | 9999.99% | 0.71% |
| March 31, 2025 | FLAVIN JOHN L | Not found | A | Stock Option (Right to Buy) | 36979 | $0.98 | 36,979.0000 | 58,445,765 | 9999.99% | 0.06% |
| March 31, 2025 | Metzger Michael A | Not found | A | Stock Option (Right to Buy) | 36979 | $0.98 | 36,979.0000 | 58,445,765 | 9999.99% | 0.06% |
| March 31, 2025 | Sullivan Lara | President ,CEO & CMO | A | Stock Option (Right to Buy) | 918308 | $0.98 | 918,308.0000 | 58,445,765 | 9999.99% | 1.57% |
| Dec. 23, 2024 | Sullivan Lara | Chief Executive Officer | A | Stock Option (Right to Buy) | 1135000 | $0.00 | 1,135,000.0000 | 60,715,041 | 9999.99% | 1.87% |
| Dec. 23, 2024 | Connealy Pamela Ann | CFO & COO | A | Stock Option (Right to Buy) | 310000 | $0.00 | 310,000.0000 | 60,715,041 | 9999.99% | 0.51% |
| Dec. 23, 2024 | Wadhane Jitendra | SVP, Chief Accounting Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 60,715,041 | 9999.99% | 0.25% |
| Nov. 26, 2024 | Connealy Pamela Ann | CFO & COO | P | Common Stock | 5450 | $2.00 | 2,314,886.0000 | 60,715,041 | 0.24% | 0.01% |
| Nov. 26, 2024 | Connealy Pamela Ann | CFO & COO | P | Common Stock | 83400 | $1.96 | 2,314,886.0000 | 60,715,041 | 3.74% | 0.14% |
| June 10, 2024 | Metzger Michael A | Not found | A | Stock Option (Right to Buy) | 70683 | $0.00 | 70,683.0000 | 39,904,603 | 9999.99% | 0.18% |
| June 7, 2024 | Palani Santhosh | Not found | A | Common Stock | 6000 | $0.00 | 6,000.0000 | 39,904,603 | 9999.99% | 0.02% |
| March 26, 2024 | Civik Thomas | Not found | A | Stock Option (Right to Buy) | 44024 | $3.83 | 44,024.0000 | 39,904,603 | 9999.99% | 0.11% |
| March 26, 2024 | Connealy Pamela Ann | CFO & COO | A | Common Stock | 328710 | $0.00 | 1,110,293.0000 | 39,904,603 | 42.06% | 0.82% |
| March 26, 2024 | Sullivan Lara | Chief Executive Officer | A | Stock Option (Right to Buy) | 1071242 | $3.83 | 1,071,242.0000 | 39,904,603 | 9999.99% | 2.68% |
| March 26, 2024 | FLAVIN JOHN L | Not found | A | Common Stock | 35219 | $0.00 | 413,015.0000 | 39,904,603 | 9.32% | 0.09% |
| March 26, 2024 | Cline Darren S | Not found | A | Common Stock | 35219 | $0.00 | 251,405.0000 | 39,904,603 | 16.29% | 0.09% |
| March 26, 2024 | Lewis-Hall Freda C | Not found | A | Common Stock | 35219 | $0.00 | 241,405.0000 | 39,904,603 | 17.08% | 0.09% |
| March 26, 2024 | Dupont Jakob | Not found | A | Common Stock | 38741 | $0.00 | 38,741.0000 | 39,904,603 | 9999.99% | 0.10% |
| March 26, 2024 | HUMPHREY RACHEL | Not found | A | Common Stock | 38741 | $0.00 | 96,805.0000 | 39,904,603 | 66.72% | 0.10% |
| March 26, 2024 | Wadhane Jitendra | SVP, Chief Accounting Officer | A | Common Stock | 131484 | $0.00 | 398,421.0000 | 39,904,603 | 49.26% | 0.33% |
| March 12, 2024 | Palani Santhosh | Not found | A | Stock Option (Right to Buy) | 69760 | $0.00 | 69,760.0000 | 39,904,603 | 9999.99% | 0.17% |
| Dec. 29, 2023 | Kobayashi Ken | Chief Medical Officer | A | Stock Option (Right to Buy) | 443514 | $0.00 | 443,514.0000 | 0 | 9999.99% | 0.00% |
| Dec. 29, 2023 | Kobayashi Ken | Chief Medical Officer | A | Stock Option (Right to Buy) | 110878 | $0.00 | 110,878.0000 | 0 | 9999.99% | 0.00% |
| Nov. 29, 2023 | Connealy Pamela Ann | CFO and COO | F | Common Stock | 36949 | $1.40 | 781,583.0000 | 0 | 4.51% | 0.00% |
| Nov. 15, 2023 | Wadhane Jitendra | Chief Accounting Officer | A | Common Stock | 40000 | $0.00 | 266,937.0000 | 0 | 17.63% | 0.00% |
| Sept. 28, 2023 | Connealy Pamela Ann | CFO and COO | P | Common Stock | 8000 | $1.87 | 818,532.0000 | 0 | 0.99% | 0.00% |
| Sept. 27, 2023 | Connealy Pamela Ann | CFO and COO | P | Common Stock | 6426 | $1.85 | 810,532.0000 | 0 | 0.80% | 0.00% |
| Sept. 27, 2023 | Wadhane Jitendra | Chief Accounting Officer | P | Common Stock | 2500 | $1.87 | 226,937.0000 | 0 | 1.11% | 0.00% |
| Sept. 22, 2023 | Dupont Jakob | Director | A | Stock Option (Right to Buy) | 392461 | $0.00 | 392,461.0000 | 0 | 9999.99% | 0.00% |
| Sept. 25, 2023 | Wadhane Jitendra | Chief Accounting Officer | P | Common Stock | 5000 | $1.77 | 224,437.0000 | 0 | 2.28% | 0.00% |
| Sept. 25, 2023 | Connealy Pamela Ann | CFO and COO | P | Common Stock | 12000 | $1.67 | 804,106.0000 | 0 | 1.51% | 0.00% |
| Sept. 22, 2023 | Connealy Pamela Ann | CFO and COO | P | Common Stock | 5000 | $1.74 | 792,106.0000 | 0 | 0.64% | 0.00% |
| Sept. 22, 2023 | Wadhane Jitendra | Chief Accounting Officer | P | Common Stock | 2500 | $1.74 | 219,437.0000 | 0 | 1.15% | 0.00% |
| Sept. 14, 2023 | Sullivan Lara | President and CEO | S | Common Stock | 100 | $2.25 | 2,412,423.0000 | 0 | 0.00% | 0.00% |
| Sept. 18, 2023 | Sullivan Lara | President and CEO | S | Common Stock | 8541 | $2.10 | 2,403,882.0000 | 0 | 0.35% | 0.00% |
| Sept. 13, 2023 | Sullivan Lara | President and CEO | F | Common Stock | 184742 | $2.13 | 2,412,523.0000 | 0 | 7.11% | 0.00% |
| Sept. 12, 2023 | Sullivan Lara | President and CEO | S | Common Stock | 4917 | $2.25 | 2,600,265.0000 | 0 | 0.19% | 0.00% |
| Sept. 11, 2023 | Sullivan Lara | President and CEO | S | Common Stock | 20000 | $2.27 | 2,605,182.0000 | 0 | 0.76% | 0.00% |
| Sept. 13, 2023 | Sullivan Lara | President and CEO | S | Common Stock | 3000 | $2.27 | 2,597,265.0000 | 0 | 0.12% | 0.00% |
| Sept. 7, 2023 | Connealy Pamela Ann | CFO and COO | A | Common Stock | 187793 | $0.00 | 782,106.0000 | 0 | 31.60% | 0.00% |
| Sept. 7, 2023 | Sullivan Lara | President and CEO | A | Common Stock | 469483 | $0.00 | 2,625,182.0000 | 0 | 21.78% | 0.00% |
| Sept. 7, 2023 | Wadhane Jitendra | Chief Accounting Officer | A | Common Stock | 93896 | $0.00 | 211,937.0000 | 0 | 79.55% | 0.00% |
| Aug. 23, 2023 | Dupont Jakob | Director | A | Stock Option (Right to buy) | 17250 | $0.00 | 17,250.0000 | 0 | 9999.99% | 0.00% |
| Aug. 23, 2023 | Dupont Jakob | Director | A | Stock Option (Right to buy) | 5879 | $0.00 | 5,879.0000 | 0 | 9999.99% | 0.00% |
| Aug. 23, 2023 | Dupont Jakob | Director | A | Stock Option (Right to buy) | 3534 | $0.00 | 3,534.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | Wadhane Jitendra | Chief Accounting Officer | A | Common Stock | 29393 | $0.00 | 118,041.0000 | 0 | 33.16% | 0.00% |
| March 24, 2023 | Wadhane Jitendra | Chief Accounting Officer | A | Common Stock | 45000 | $0.00 | 88,648.0000 | 0 | 103.10% | 0.00% |
| March 24, 2023 | Wadhane Jitendra | Chief Accounting Officer | D | Stock Option (Right to buy) | 157257 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 24, 2023 | Wadhane Jitendra | Chief Accounting Officer | A | Stock Option (Right to buy) | 157257 | $0.00 | 157,257.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | Lewis-Hall Freda C | Director | A | Common Stock | 139355 | $0.00 | 206,186.0000 | 0 | 208.52% | 0.00% |
| March 24, 2023 | HUMPHREY RACHEL | Director | A | Common Stock | 58064 | $0.00 | 58,064.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | FLAVIN JOHN L | Director | A | Common Stock | 139355 | $0.00 | 377,796.0000 | 0 | 58.44% | 0.00% |
| March 24, 2023 | Cline Darren S | Director | A | Common Stock | 139355 | $0.00 | 216,186.0000 | 0 | 181.38% | 0.00% |
| March 24, 2023 | Civik Thomas | Director | A | Common Stock | 139355 | $0.00 | 221,886.0000 | 0 | 168.85% | 0.00% |
| March 24, 2023 | Sullivan Lara | President and CEO | A | Common Stock | 703379 | $0.00 | 2,155,699.0000 | 0 | 48.43% | 0.00% |
| March 24, 2023 | Sullivan Lara | President and CEO | D | Stock Option (Right to buy) | 990461 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 24, 2023 | Sullivan Lara | President and CEO | D | Stock Option (Right to buy) | 61825 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 24, 2023 | Sullivan Lara | President and CEO | A | Stock Option (Right to buy) | 990461 | $0.00 | 990,461.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | Sullivan Lara | President and CEO | A | Stock Option (Right to buy) | 61825 | $0.00 | 61,825.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | Yanchik Connealy Pamela | CFO and COO | A | Common Stock | 209803 | $0.00 | 594,313.0000 | 0 | 54.56% | 0.00% |
| March 24, 2023 | Yanchik Connealy Pamela | CFO and COO | D | Stock Option (Right to buy) | 322265 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 24, 2023 | Yanchik Connealy Pamela | CFO and COO | D | Stock Option (Right to buy) | 10304 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 24, 2023 | Yanchik Connealy Pamela | CFO and COO | A | Stock Option (Right to buy) | 322265 | $0.00 | 322,265.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | Yanchik Connealy Pamela | CFO and COO | A | Stock Option (Right to buy) | 10304 | $0.00 | 10,304.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | Feingold Jay | Chief Medical Officer | A | Common Stock | 209803 | $0.00 | 730,345.0000 | 0 | 40.30% | 0.00% |
| March 24, 2023 | Feingold Jay | Chief Medical Officer | D | Stock Option (Right to buy) | 157257 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 24, 2023 | Feingold Jay | Chief Medical Officer | D | Stock Option (Right to buy) | 17517 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 24, 2023 | Feingold Jay | Chief Medical Officer | A | Stock Option (Right to buy) | 157257 | $0.00 | 157,257.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | Feingold Jay | Chief Medical Officer | A | Stock Option (Right to buy) | 17517 | $0.00 | 17,517.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Yanchik Connealy Pamela | Chief Financial Officer | A | Common Stock | 43493 | $0.00 | 384,510.0000 | 0 | 12.75% | 0.00% |
| Jan. 3, 2023 | Feingold Jay | Chief Medical Officer | A | Common Stock | 53931 | $0.00 | 520,542.0000 | 0 | 11.56% | 0.00% |
| Jan. 3, 2023 | Sullivan Lara | Chief Executive Officer | A | Common Stock | 95684 | $0.00 | 1,452,320.0000 | 0 | 7.05% | 0.00% |